Suping Li

8.4k total citations · 3 hit papers
162 papers, 6.5k citations indexed

About

Suping Li is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Suping Li has authored 162 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 32 papers in Oncology and 24 papers in Biomedical Engineering. Recurrent topics in Suping Li's work include Advanced biosensing and bioanalysis techniques (21 papers), Nanoplatforms for cancer theranostics (15 papers) and RNA Interference and Gene Delivery (13 papers). Suping Li is often cited by papers focused on Advanced biosensing and bioanalysis techniques (21 papers), Nanoplatforms for cancer theranostics (15 papers) and RNA Interference and Gene Delivery (13 papers). Suping Li collaborates with scholars based in China, United States and Australia. Suping Li's co-authors include Guangjun Nie, Gregory J. Anderson, Yanhua Tian, Tianjiao Ji, Jingyan Wei, Motao Zhu, Jian Song, Yinlong Zhang, Guobao Xu and Jianping Lai and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Suping Li

146 papers receiving 6.4k citations

Hit Papers

A doxorubicin delivery platform using engineered natural ... 2013 2026 2017 2021 2013 2018 2023 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suping Li China 35 3.7k 2.0k 1.3k 996 652 162 6.5k
Baoan Chen China 41 2.8k 0.8× 1.7k 0.9× 1.1k 0.9× 1.3k 1.3× 501 0.8× 195 5.7k
Jianfeng Guo China 48 2.3k 0.6× 1.3k 0.7× 820 0.6× 1.1k 1.1× 1.1k 1.7× 179 6.8k
Jiang Xia Hong Kong 42 4.3k 1.1× 1.2k 0.6× 1.1k 0.9× 595 0.6× 377 0.6× 167 7.1k
Yin Wang China 48 2.8k 0.8× 2.0k 1.0× 734 0.6× 2.2k 2.2× 521 0.8× 248 8.3k
Xiaoding Xu China 42 2.9k 0.8× 2.3k 1.2× 998 0.8× 1.7k 1.7× 388 0.6× 118 6.5k
Yongyi Zeng China 40 2.4k 0.7× 2.4k 1.2× 805 0.6× 617 0.6× 736 1.1× 222 6.2k
Jingfeng Liu China 47 2.8k 0.7× 3.0k 1.5× 1.4k 1.1× 999 1.0× 973 1.5× 360 8.1k
Zihua Wang China 39 2.5k 0.7× 1.0k 0.5× 595 0.5× 602 0.6× 781 1.2× 184 5.9k
Phei Er Saw China 40 3.0k 0.8× 2.2k 1.1× 1.1k 0.8× 1.3k 1.3× 973 1.5× 126 6.3k
Lu Gan China 47 3.3k 0.9× 2.4k 1.2× 1.2k 0.9× 1.3k 1.3× 825 1.3× 182 7.0k

Countries citing papers authored by Suping Li

Since Specialization
Citations

This map shows the geographic impact of Suping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suping Li more than expected).

Fields of papers citing papers by Suping Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suping Li. The network helps show where Suping Li may publish in the future.

Co-authorship network of co-authors of Suping Li

This figure shows the co-authorship network connecting the top 25 collaborators of Suping Li. A scholar is included among the top collaborators of Suping Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suping Li. Suping Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Zhouliang, Zefang Lu, Feilong Qi, et al.. (2025). Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy. Cell Reports Medicine. 6(3). 101984–101984.
2.
Zhang, Yongpeng, Bozhao Li, Xuan Liu, et al.. (2025). DNA computing function switching by programming base stacking interactions with minimal molecular architecture changes. Nature Communications. 16(1). 9369–9369.
3.
Wang, Jianfeng, et al.. (2024). The developmental processes of ventricular septal defects with outflow tract malalignment. Annals of Anatomy - Anatomischer Anzeiger. 255. 152293–152293. 1 indexed citations
5.
Wen, Xiaohong, Mei Yang, Lie Li, et al.. (2023). Enzymatically controlled DNA tetrahedron nanoprobes for specific imaging of ATP in tumor. Chinese Chemical Letters. 35(8). 109291–109291. 6 indexed citations
6.
Zhang, Xiuping, Bozhao Li, Zefang Lu, et al.. (2023). Nanoparticle-based combination of LMWH and doxorubicin for the efficient treatment of hepatocellular carcinoma with portal vein tumor thrombus. Nano Today. 49. 101787–101787. 6 indexed citations
7.
Li, Bozhao, Fei Zhu, Zefang Lu, et al.. (2023). Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer. Cancer Research. 83(17). 2924–2937. 11 indexed citations
8.
Tan, Mixiao, Wenping Huang, Jie Zhang, et al.. (2023). Nutrient-sensing nanoprotoplast augments tumor accumulation and immune response with short-term starvation. Nano Today. 49. 101762–101762. 4 indexed citations
9.
Li, Suping, Fei Huang, Ru Xu, et al.. (2023). A novel compound heterozygous mutation in TUBB8 causing early embryonic developmental arrest. Journal of Assisted Reproduction and Genetics. 40(4). 753–763. 5 indexed citations
10.
Yuan, Junling, Xuhong Li, Qikun Zhang, & Suping Li. (2023). Partial filterable optical networking: A gradual upgrade scheme for large-scale backbone networks. Optical Fiber Technology. 82. 103624–103624. 1 indexed citations
11.
Xu, Yu, Ke Ma, Fan Zhang, et al.. (2023). Association between baseline C‑reactive protein level and survival outcomes for cancer patients treated with immunotherapy: A meta‑analysis. Experimental and Therapeutic Medicine. 26(2). 7 indexed citations
12.
Zhang, Feng, Suping Li, Bin Yu, et al.. (2021). High throughput microRNAs sequencing profile of serum exosomes in women with and without polycystic ovarian syndrome. PeerJ. 9. e10998–e10998. 22 indexed citations
13.
Dong, Jinhua, et al.. (2018). EGFR aptamer-conjugated liposome-polycation-DNA complex for targeted delivery of SATB1 small interfering RNA to choriocarcinoma cells. Biomedicine & Pharmacotherapy. 107. 849–859. 26 indexed citations
14.
Pandit, Harshul, et al.. (2018). Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma. BMC Cancer. 18(1). 783–783. 46 indexed citations
15.
Xiong, Jinbo, et al.. (2016). Research progress on secure data deduplication in cloud. SHILAP Revista de lepidopterología. 37(11). 180. 5 indexed citations
16.
Zhao, Ying, Tianjiao Ji, Hai Wang, et al.. (2014). Self-assembled peptide nanoparticles as tumor microenvironment activatable probes for tumor targeting and imaging. Journal of Controlled Release. 177. 11–19. 58 indexed citations
17.
Liang, Peizhou, et al.. (2013). KPNB1, XPO7 and IPO8 Mediate the Translocation ofNF‐κB/p65 into the Nucleus. Traffic. 14(11). 1132–1143. 84 indexed citations
18.
Li, Suping. (2010). Control system design of a facial robot. Journal of Machine Design.
19.
Li, Suping. (2008). Surface Modes of Dielectric Slab Waveguides with a Left Handed Material Substrate. Bandaoti guangdian. 1 indexed citations
20.
Zhang, Yuanying, Xiaorong Liu, Yimei Fan, et al.. (2006). Germline mutations and polymorphic variants in MMR, E‐cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China. International Journal of Cancer. 119(11). 2592–2596. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026